• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝状α-突触核蛋白包涵体将多系统萎缩与帕金森病及路易体痴呆联系起来。

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

作者信息

Spillantini M G, Crowther R A, Jakes R, Cairns N J, Lantos P L, Goedert M

机构信息

MRC Centre for Brain Repair and Department of Neurology, University of Cambridge, UK.

出版信息

Neurosci Lett. 1998 Jul 31;251(3):205-8. doi: 10.1016/s0304-3940(98)00504-7.

DOI:10.1016/s0304-3940(98)00504-7
PMID:9726379
Abstract

Alpha-synuclein forms the major component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Here we show that alpha-synuclein is also the major component of the filamentous inclusions of multiple system atrophy which comprises several neurodegenerative diseases with a shared filamentous pathology in nerve cells and glial cells. These findings provide an unexpected link between multiple system atrophy and Lewy body disorders and establish that alpha-synucleinopathies constitute a major class of human neurodegenerative disorder.

摘要

α-突触核蛋白是路易小体和路易神经突的主要成分,这是帕金森病和路易体痴呆的典型神经病理学特征。我们在此表明,α-突触核蛋白也是多系统萎缩的丝状包涵体的主要成分,多系统萎缩包括几种神经退行性疾病,在神经细胞和胶质细胞中具有共同的丝状病理学特征。这些发现揭示了多系统萎缩与路易体疾病之间出人意料的联系,并确定α-突触核蛋白病构成了人类神经退行性疾病的一大类。

相似文献

1
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.丝状α-突触核蛋白包涵体将多系统萎缩与帕金森病及路易体痴呆联系起来。
Neurosci Lett. 1998 Jul 31;251(3):205-8. doi: 10.1016/s0304-3940(98)00504-7.
2
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.α-突触核蛋白病:帕金森病、路易体痴呆和多系统萎缩。
Ann N Y Acad Sci. 2000;920:16-27. doi: 10.1111/j.1749-6632.2000.tb06900.x.
3
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.来自帕金森病和路易体痴呆患者路易小体丝状包涵体中的α-突触核蛋白。
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73. doi: 10.1073/pnas.95.11.6469.
4
TIGAR inclusion pathology is specific for Lewy body diseases.TIGAR 包涵体病理学是路易体病的特征。
Brain Res. 2019 Mar 1;1706:218-223. doi: 10.1016/j.brainres.2018.09.032. Epub 2018 Sep 26.
5
Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.聚集素/载脂蛋白J与皮质路易小体相关:α-突触核蛋白病病例的免疫组织化学研究
Acta Neuropathol. 2002 Sep;104(3):225-30. doi: 10.1007/s00401-002-0546-4. Epub 2002 May 9.
6
Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.帕金森病和皮质路易体病中的黑质和皮质路易小体以及营养不良性黑质神经突含有α-突触核蛋白免疫反应性。
J Neuropathol Exp Neurol. 1998 Apr;57(4):334-7. doi: 10.1097/00005072-199804000-00005.
7
Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.组织转谷氨酰胺酶诱导的α-突触核蛋白聚集:对帕金森病和路易体痴呆中路易体形成的影响。
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2047-52. doi: 10.1073/pnas.0438021100. Epub 2003 Feb 7.
8
Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.多芬定位于帕金森病、路易体痴呆、多系统萎缩和肌萎缩侧索硬化症中的泛素化包涵体。
Am J Pathol. 2003 Aug;163(2):609-19. doi: 10.1016/s0002-9440(10)63688-7.
9
Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.α-突触核蛋白在路易体病的浦肯野细胞中积聚,但在多系统萎缩中则不然。
J Neuropathol Exp Neurol. 2003 Aug;62(8):812-9. doi: 10.1093/jnen/62.8.812.
10
Parkinson's disease and other alpha-synucleinopathies.帕金森病和其他α-突触核蛋白病。
Clin Chem Lab Med. 2001 Apr;39(4):308-12. doi: 10.1515/CCLM.2001.047.

引用本文的文献

1
Co-infection with two α-synuclein strains reveals novel synergistic interactions.两种α-突触核蛋白毒株的共同感染揭示了新的协同相互作用。
bioRxiv. 2025 Aug 22:2025.08.17.670736. doi: 10.1101/2025.08.17.670736.
2
Altered gut microbial networks and metabolic pathways in multiple system atrophy: a comparative 16S rRNA study.多系统萎缩中肠道微生物网络和代谢途径的改变:一项比较性16S rRNA研究
Front Neurosci. 2025 Aug 13;19:1623165. doi: 10.3389/fnins.2025.1623165. eCollection 2025.
3
Evidence of a novel α-synuclein strain isolated from a Parkinson's disease with dementia patient sample.
从一名帕金森病合并痴呆患者样本中分离出新型α-突触核蛋白毒株的证据。
Acta Neuropathol Commun. 2025 Aug 18;13(1):177. doi: 10.1186/s40478-025-02093-x.
4
Alpha-Synuclein Fibril Structures Cluster into Distinct Classes.α-突触核蛋白原纤维结构聚集成不同类别。
bioRxiv. 2025 May 2:2025.04.30.651534. doi: 10.1101/2025.04.30.651534.
5
Abnormal α-synuclein binds to synaptotagmin 13, impairing extracellular vesicle release in synucleinopathies.异常的α-突触核蛋白与突触结合蛋白13结合,损害突触核蛋白病中细胞外囊泡的释放。
Transl Neurodegener. 2025 Jun 23;14(1):32. doi: 10.1186/s40035-025-00493-6.
6
Lewy-MSA hybrid fold drives distinct neuronal α-synuclein pathology.路易体-多系统萎缩混合折叠驱动独特的神经元α-突触核蛋白病变。
Commun Biol. 2025 Jun 16;8(1):929. doi: 10.1038/s42003-025-08355-7.
7
Intracellular Inclusions Induced by Patient-Derived and Amplified α-Synuclein Aggregates Are Morphologically Indistinguishable.由患者来源并扩增的α-突触核蛋白聚集体诱导产生的细胞内包涵体在形态上无法区分。
Cells. 2025 May 9;14(10):684. doi: 10.3390/cells14100684.
8
Dysregulation of Monounsaturated Fatty Acids is Related to α-Synuclein in Multiple System Atrophy.单不饱和脂肪酸的失调与多系统萎缩中的α-突触核蛋白有关。
Mov Disord. 2025 May 23. doi: 10.1002/mds.30248.
9
Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies.用于治疗α-突触核蛋白病的单克隆α-突触核蛋白抗体amlenetug(Lu AF82422)的合理选择。
NPJ Parkinsons Dis. 2025 May 22;11(1):132. doi: 10.1038/s41531-024-00849-1.
10
Autophagy Dysfunction and Neurodegeneration: Where Does It Go Wrong?自噬功能障碍与神经退行性变:问题出在哪里?
J Mol Biol. 2025 Sep 15;437(18):169219. doi: 10.1016/j.jmb.2025.169219. Epub 2025 May 16.